Maternal and developmental toxicity of ayahuasca in wistar rats

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 89, Issue 3, 2010, Pages 207-212

  Oliveira, Carolina Dizioli Rodrigues ^a   Moreira, Camila Queiroz ^a   De Sá, Lilian Rose Marques ^a   Spinosa, Helenice De Souza ^a   Yonamine, Mauricio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ayahuasca; Banisteriopsis caapi; Maternal toxicity; Psychotria viridis; Rats; Teratogenicity

Indexed keywords

AYAHUASCA; HERBACEOUS AGENT; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BANISTERIOPSIS; BANISTERIOPSIS CAAPI; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; FETUS; FOOD INTAKE; GESTATION PERIOD; MALE; NONHUMAN; ORGAN WEIGHT; PLANT LEAF; PLANT STEM; PRIORITY JOURNAL; PSYCHOTRIA; PSYCHOTRIA VIRIDIS; RAT; REPRODUCTIVE TOXICITY; SKELETON MALFORMATION; VISCERA; WEIGHT GAIN; WISTAR RAT; ANIMAL; BONE; DRINKING BEHAVIOR; DRUG EFFECTS; EMBRYO DEVELOPMENT; ENVIRONMENTAL EXPOSURE; FEEDING BEHAVIOR; HUMAN; ORGAN SIZE; PREGNANCY; REPRODUCTION; TOXICITY TESTING;

BANISTERIOPSIS CAAPI; PSYCHOTRIA VIRIDIS; RATTUS; RATTUS NORVEGICUS;

ANIMALS; BANISTERIOPSIS; BONE AND BONES; DRINKING BEHAVIOR; EMBRYONIC DEVELOPMENT; FEEDING BEHAVIOR; FEMALE; FETUS; HUMANS; MALE; MATERNAL EXPOSURE; ORGAN SIZE; PREGNANCY; RATS; RATS, WISTAR; REPRODUCTION; TOXICITY TESTS; VISCERA;

EID: 77953581703     PISSN: 15429733     EISSN: 15429741     Source Type: Journal    
DOI: 10.1002/bdrb.20244     Document Type: Article

References (31)

1. Abdel-Hamid HA, Abdel-Rahman MS, Abdel-Rahman SA. 1996. Teratogenic effect of diphenylhydantoin and/or fluphenazine in mice. J Appl Toxicol 16:221-225.
2. Alkalay AL, Graham Jr JM, Pomerance JJ. 1998. Evaluation of neonates born with intrauterine growth retardation: review and practice guidelines. J Perinatol 18:142-151.
3. Amacher DE, Schomaker SJ, Burkhardt JE. 1998. The relationship among microsomal enzyme induction, liver weight and histological change in rat toxicology studies. Food Chem Toxicol 36:831-839.
4. Andersen H, Larsen S, Spliid H, Christensen ND. 1999. Multivariate statistical analysis of organ weights in toxicity studies. Toxicology 136:67-77. (Pubitemid 29425797)
5. Bailey SA, Zidell RH, Perry RW. 2004. Relationships between organ weight and body/brain weight in the rat: what is the best analytical endpoint? Toxicol Pathol 32:448-466.
6. Barrow MV, Taylor WJ. 1969. A rapid method for detecting malformations in rat fetuses. J Morphol 127:291-305.
7. Brazil, National Anti-Drug Council Resolution, no. 4, November 4, 2004. Federal Official Gazette of the Federative Republic of Brazil, Brasilia, November 8, 2004.
8. Callaway JC. 2005. Fast and slow metabolizers of Hoasca. J Psychoactive Drugs 37:157-161.
9. Callaway JC, McKenna DJ, Grob CS, Brito GS, Raymon LP, Poland RE, Andrade EN, Andrade EO, Mash DC. 1999. Pharmacokinetics of Hoasca alkaloids in healthy humans. J Ethnopharmacol 65:243-256.
10. Carrascosa A, Yeste D, Copil A, Audi L, Gusinye M, Vicens-Calvet E, Clemente M. 2004. Fetal growth regulation and intrauterine growth retardation. J Pediatr Endocrinol Metab 17(Suppl 3):435-443.
11. Chahoud I, Ligensa A, Dietzel L, Faqi AS. 1999. Correlation between maternal toxicity and embryo/fetal effects. Reprod Toxicol 13:375-381.
12. Chung MK, Kim CY, Kim JC. 2007. Reproductive toxicity evaluation of a new camptothecin anticancer agent, CKD-602, in pregnant/lactating female rats and their offspring. Cancer Chemother Pharmacol 59:383-395.
13. EPA (U.S. Environmental Protection Agency). 2002. Harmonized Test Guideline OPPTS 870.1100 Acute Oral Toxicity. Washington, DC: Office of Health and Environmental Assessment. 2002. http:// www.epa.gov/oppfead1/harmonization. pdf
14. Gable RS. 2007. Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction 102:24-34.
15. Guide for Care and Use of Laboratory Animals. 1996. Institute of Laboratory Animal Research, Comission on Life Sciences, National Research Council. Washington, DC: National Academy Press. 124p.
16. Halpern JH, Sherwood AR, Passie T, Blackwell KC, Ruttenber AJ. 2008. Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament. Med Sci Monit 14:SR15-S22.
17. Holson JF, Nemec MD, Stump DG, Kaufman LE, Lindstrom P, Varsho BJ. 2006. Significance, Reliability, and Inerpretation of developmental and reproductive toxicity study findings. In: Hood RD, editor. Developmental and reproductive toxicology: a practical approach, 2nd ed. Boca Raton: Taylor & Francis Group. p 329-424.
18. Hood RD. 2006. Principles of developmental toxicology revisited. In: Hood RD, editor. Developmental and reproductive toxicology: a practical approach, 2nd ed. Boca Raton: Taylor & Francis Group. p 3-14.
19. Khera KS. 1985. Maternal toxicity: a possible etiological factor in embryo-fetal deaths and fetal malformations of rodent-rabbit species. Teratology 31:129-153.
20. Kim JC, Shin DH, Kim SH, Kim JK, Park SC, Son WC, Lee HS, Suh JE, Kim CY, Ha CS, Chung MK. 2004. Subacute toxicity evaluation of a new camptothecin anticancer agent CKD-602 administered by intravenous injection to rats. Regul Toxicol Pharmacol 40:356-369.
21. Makris SL, Solomon HM, Clark R, Shiota K, Barbellion S, Buschmann J, Ema M, Fujiwara M, Grote K, Hazelden KP, Hew KW, Horimoto M, Ooshima Y, Parkinson M, Wise LD. 2009. Terminology of developmental abnormalities in common laboratory mammals (Version 2). Birth Defects Res B Dev Reprod Toxicol 86:227-327.
22. McKenna DJ. 2004. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacol Therapeut 102:111-129.
23. Paumgartten F, Solecki R, Buschmann J, Clark R, Grote K, Rauch M, Chahoud I. 2009. Harmonization of terminology in developmental toxicology: the quest for a more precise description and a harmonized classification of fetal observations. Reprod Toxicol 27:8-13.
24. Pires AP, De Oliveira CD, Moura S, Dorr FA, Silva WA, Yonamine M. 2009. Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage. Phytochem Anal 20:149-153.
25. Riba J, Barbanoj MJ. 2005. Bringing ayahuasca to the clinical research laboratory. J Psychoactive Drugs 37:219-230. (Pubitemid 41105820)
26. Riba J, Rodriguez-Fornells A, Urbano G, Morte A, Antonijoan R, Montero M, Callaway JC, Barbanoj MJ. 2001. Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacology 154:85-95.
27. Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ. 2003. Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J Pharmacol Exp Therapeut 306:73-83.
28. Salewski E. 1964. Faerbemethoden zum makroskopischen nachweis von implantationsstellen am uterus der ratte. Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 4:247-257.
29. Solecki R, Bergmann B, Burgin H, Buschmann J, Clark R, Druga A, Van Duijnhoven EA, Duverger M, Edwards J, Freudenberger H, Guittin P, Hakaite P, Heinrich-Hirsch B, Hellwig J, Hofmann T, Hubel U, Khalil S, Klaus A, Kudicke S, Lingk W, Meredith T, Moxon M, Muller S, Paul M, Paumgartten F, Rohrdanz E, Pfeil R, Rauch-Ernst M, Seed J, Spezia F, Vickers C, Woelffel B, Chahoud I. 2003. Harmonization of rat fetal external and visceral terminology and classification. Report of the Fourth Workshop on the Terminology in Developmental Toxicology, Berlin, 18-20 April 2002. Reprod Toxicol 17:625-637.
30. Staples RE, Schnell VL. 1964. Refinements in rapid clearing technic in the Koh-Alizarin Red S method for fetal bone. Stain Technol 39:61-63.
31. Wilson JG. 1965. Methods for administering agents and detecting malformations in experimental animals. In: Wilson JG, Warkany J, editors. Teratology: principles and techniques. Chicago: University of Chicago Press. p 262-277.